Misra C H, Shelat H, Smith R C
Eur J Pharmacol. 1981 Dec 17;76(4):317-24. doi: 10.1016/0014-2999(81)90102-3.
The effects of age on alterations in brain dopaminergic (spiperone), beta-adrenergic (DHA), alpha-adrenergic (WB-4101), and cholinergic (QNB) binding induced by chronic administration of fluphenazine was studied in the rat. Compared to age-matched saline controls, older-age (25 month) fluphenazine rats showed: (a) a similar percent increase in specific spiperone binding (at 0.1 nM) but a slightly smaller increase in the Bmax of spiperone binding in the striatum than younger fluphenazine-treated rats; (b) a substantially greater increase in the Bmax of DHA binding and a slightly greater increase in Bmax of WB-4101 binding in the cerebral cortex than younger fluphenazine-treated rats. There was no significant interaction of age with the effect of chronic fluphenazine on QNB binding in rat striatum.
研究了年龄对大鼠长期服用氟奋乃静所致脑多巴胺能(螺哌隆)、β-肾上腺素能(DHA)、α-肾上腺素能(WB-4101)和胆碱能(QNB)结合改变的影响。与年龄匹配的生理盐水对照组相比,老年(25个月)氟奋乃静处理的大鼠表现为:(a)纹状体中特异性螺哌隆结合(0.1 nM时)的百分比增加相似,但螺哌隆结合的Bmax增加幅度略小于年轻氟奋乃静处理的大鼠;(b)大脑皮层中DHA结合的Bmax增加幅度显著大于年轻氟奋乃静处理的大鼠,WB-4101结合的Bmax增加幅度略大于年轻氟奋乃静处理的大鼠。年龄与慢性氟奋乃静对大鼠纹状体QNB结合的影响之间无显著相互作用。